Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;182(6):1387-1399.
doi: 10.1002/ajmg.a.61571. Epub 2020 Mar 31.

Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation

Affiliations

Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation

Zeynep H Coban-Akdemir et al. Am J Med Genet A. 2020 Jun.

Abstract

Background: Wolff-Parkinson-White (WPW) syndrome is a relatively common arrhythmia affecting ~1-3/1,000 individuals. Mutations in PRKAG2 have been described in rare patients in association with cardiomyopathy. However, the genetic basis of WPW in individuals with a structurally normal heart remains poorly understood. Sudden death due to atrial fibrillation (AF) can also occur in these individuals. Several studies have indicated that despite ablation of an accessory pathway, the risk of AF remains high in patients compared to general population.

Methods: We applied exome sequencing in 305 subjects, including 65 trios, 80 singletons, and 6 multiple affected families. We used de novo analysis, candidate gene approach, and burden testing to explore the genetic contributions to WPW.

Results: A heterozygous deleterious variant in PRKAG2 was identified in one subject, accounting for 0.6% (1/151) of the genetic basis of WPW in this study. Another individual with WPW and left ventricular hypertrophy carried a known pathogenic variant in MYH7. We found rare de novo variants in genes associated with arrhythmia and cardiomyopathy (ANK2, NEBL, PITX2, and PRDM16) in this cohort. There was an increased burden of rare deleterious variants (MAF ≤ 0.005) with CADD score ≥ 25 in genes linked to AF in cases compared to controls (P = .0023).

Conclusions: Our findings show an increased burden of rare deleterious variants in genes linked to AF in WPW syndrome, suggesting that genetic factors that determine the development of accessory pathways may be linked to an increased susceptibility of atrial muscle to AF in a subset of patients.

Keywords: ANK2; Wolff-Parkinson-White (WPW) syndrome; atrial fibrillation; exome sequencing.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

Baylor College of Medicine (BCM) and Miraca Holdings Inc. have formed a joint venture with shared ownership and governance of Baylor Genetics (BG), formerly the Baylor Miraca Genetics Laboratories (BMGL), which performs clinical exome sequencing. J.R.L. serves on the Scientific Advisory Board of BG. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases and bacterial genomic fingerprinting. J.W.B. contributed to this work while employed by BCM and is currently a full-time employee of Illumina, Inc. Other authors have no disclosures relevant to the manuscript.

Figures

Figure 1:
Figure 1:. Schematic of methodology applied for prioritization of candidate genes
Figure 2.
Figure 2.. Burden analysis of rare deleterious variants in AF genes in WPW affecteds.
(A) An increased proportion of WPW European cases have 1 or 2 rare (MAF<=0.005) and deleterious (CADD>=25) alleles in AF genes (N=66). The column plot shows the proportion of exomes in WPW European affecteds (n=83, depicted in green), WPW European unaffected first degree relatives (n=106, depicted in brown) and ARIC European unaffected controls (ARIC-controls) (n=3,137, depicted in purple) (y-axis) in terms of the number of rare (MAF <=0.005) and deleterious (CADD score >=25) alleles in AF genes carried in their personal genomes (x-axis). (B) The average rare and deleterious allele count in AF genes was compared between affecteds vs. ARIC-controls (top), unaffected first degree relatives vs. ARIC-controls (middle) and affecteds vs. unaffected first degree relatives (bottom) using Mann-Whitney U test. 10,000 permutations were applied by shuffling the allele counts between each pair of group of patients. Gray boxplots shows the distribution of Mann-Whitney U test P-values regarding each permutation. The observed P-value was examined in terms of its location the distribution of 10,000 P-values. This analysis revealed that the average allele rare and deleterious count of AF genes in affecteds was significantly greater (0.277) as compared to ARIC-controls (average allele count=0.18) (Permutation test one-tailed P-value =0.0023) and unaffected first-degree relatives (average allele count=0.207) (Permutation test one-tailed P-value =0.033). There was not a significant increase in rare and deleterious variant burden in AF genes in unaffected relatives [n=106] (average allele count=0.207) compared to ARIC- controls [N=3,064] (average allele count=0.18) (Permutation test one-tailed P-value =0.297). (C) The heatplot shows the AF genes, in which an affected carries a rare variant. Each row corresponds to a gene and each column corresponds to a patient. Red rectangles show that there is a rare and deleterious variant in the AF gene with its HUGO gene symbol presented in the corresponding row in the individual with ID presented in the corresponding column.

References

    1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, …Sunyaev SR (2010). A method and server for predicting damaging missense mutations. Nat Methods, 7(4), 248–9. doi:nmeth0410-248 [pii] 10.1038/nmeth0410-248 - DOI - PMC - PubMed
    1. Ahmad F, Arad M, Musi N, He H, Wolf C, Branco D, …Seidman JG (2005). Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. Circulation, 112(20), 3140–8. doi:CIRCULATIONAHA.105.550806 [pii] 10.1161/CIRCULATIONAHA.105.550806 - DOI - PubMed
    1. Arad M, Maron BJ, Gorham JM, Johnson WH Jr., Saul JP, Perez-Atayde AR, …Seidman JG (2005). Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med, 352(4), 362–72. doi:352/4/362 [pii] 10.1056/NEJMoa033349 - DOI - PubMed
    1. Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, …Seidman JG (2003). Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation, 107(22), 2850–6. doi:10.1161/01.CIR.0000075270.13497.2B 01.CIR.0000075270.13497.2B [pii] - DOI - PubMed
    1. Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, …Casellas R (2012). The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dube syndrome is required for murine B-cell development. Blood, 120(6), 1254–61. doi:blood-2012-02-410407 [pii] 10.1182/blood-2012-02-410407 - DOI - PMC - PubMed

Publication types

MeSH terms